Herausforderungen

HCP engagement was becoming increasingly digital and time-constrained, making it harder to sustain meaningful scientific relationships. Existing initiatives were fragmented across channels, and participation in education and collaboration programs varied widely by region and specialty.

Key challenges included:

• Inconsistent CME and certification participation: Low completion rates for product learning modules reduced confidence and slowed adoption.
• Slower therapeutic evaluation cycles: Sample requests, starter program adoption, and clinical document engagement lacked consistent follow-through.
• Limited visibility into digital engagement quality: Webinar and resource participation existed, but it was hard to track and reward meaningful engagement.
• Difficulty sustaining clinical collaboration: Trial participation and real-world evidence initiatives needed stronger recognition and continuity.
• Formulary advocacy was hard to scale: Hospital-level access support depended on a small set of champions, with limited structured recognition.
• Minimal recognition tied to patient outcomes and best practices: Physicians delivering strong outcomes had limited opportunities for formal acknowledgment and thought leadership amplification.

Personas involved

• Healthcare Professionals (HCPs): Physicians and specialists who engage in CME, certifications, product evaluation, digital scientific learning, and clinical collaboration initiatives.

• Medical Affairs Teams: Design scientific programs, validate learning content, manage evidence-generation initiatives, and govern compliant engagement.

• Clinical Operations & Research Teams: Coordinate trial participation milestones, investigator engagement, and real-world evidence programs.

• Market Access Teams: Support formulary pathways and institutional engagement programs aligned to access expansion goals.

• Commercial / Field Teams (Sales & KAMs): Drive adoption journeys through compliant education touchpoints and HCP enablement, coordinating engagement triggers through CRM workflows.

• Program Admin / Super Admin: Configures Empuls rules, reward budgets, compliance approvals, segmentation by specialty/region, and dashboards for engagement outcomes.

The solution

The company needed a scalable, compliant way to reward high-value HCP engagement—across learning, research collaboration, and digital scientific participation—while ensuring transparency, measurable reporting, and seamless operational workflows. Xoxoday Empuls delivered a unified engagement and recognition layer for HCP programs.

• CME & certification rewards to accelerate professional learning: Xoxoday Empuls rewarded physicians who completed CME modules, product certifications, and clinical learning pathways—driving deeper therapeutic confidence and consistent knowledge adoption across specialties.

• Clinical trial participation recognition to strengthen research partnerships: The company recognized principal investigators and participating HCPs for clinical study milestones and real-world evidence contribution—supporting longer-term collaboration and engagement continuity.

• Patient outcome recognition to build thought leadership and peer influence: Xoxoday Empuls enabled structured recognition for physicians whose treatment protocols delivered strong patient outcomes—supported by recognition moments and professional visibility within approved scientific communities and peer forums.

• Product evaluation rewards to shorten the adoption cycle: Physicians were incentivized to request samples, access clinical documentation, enroll patients in starter programs, and complete structured evaluation steps—helping speed-to-confidence for new therapies.

• Formulary advocacy recognition to support institutional access: The program acknowledged HCPs who supported formulary discussions, clinical committee engagement, and hospital inclusion pathways—recognizing their contribution to expanding patient access.

• Digital engagement incentives to keep virtual scientific relationships active: Xoxoday Empuls rewarded meaningful participation in webinars, virtual symposiums, and scientific content hubs—helping sustain engagement in a digitally dominant environment.

• Integrations to automate triggers and improve reporting: Xoxoday Empuls integrated with CRM, LMS/CME systems, and webinar platforms to automate reward eligibility based on verifiable actions (module completion, attendance, content engagement). Dashboards consolidated region-wise participation, specialty trends, and engagement lift—reducing manual tracking and improving governance.

Impact

• 41% increase in CME and certification completion rates, driven by structured learning rewards and automated completion triggers.
• 27% faster therapeutic evaluation cycles, supported by incentives for sample requests, clinical documentation consumption, and starter program actions.
• 2.4× increase in webinar participation and scientific content engagement, enabled by digital engagement incentives and targeted segmentation.
• 19% growth in investigator participation for evidence programs, strengthened by milestone-based recognition for research collaboration.
• Higher institutional engagement and formulary momentum, supported by recognition for HCP champions in access pathways.
• INR 8.7 crore in engagement rewards processed annually, improving transparency, consistency, and measurable program governance across regions.

Conclusion

By implementing Xoxoday Empuls, the branded prescription pharma company modernized HCP engagement across education, research collaboration, and digital scientific participation. From CME rewards and product evaluation incentives to formulary advocacy recognition and outcome-based visibility, Xoxoday Empuls helped build stronger clinical partnerships—driving more consistent engagement, faster adoption journeys, and deeper trust across India’s healthcare ecosystem.